Cleared Traditional

TeraRecon Neuro (K220349) - FDA 510(k) Clearance

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K220349 · Terarecon,Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2022
Decision
186d
Days
Class 2
Risk

K220349 is an FDA 510(k) clearance for the TeraRecon Neuro. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Terarecon,Inc. (Durham, US). The FDA issued a Cleared decision on August 12, 2022 after a review of 186 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Terarecon,Inc. devices

Submission Details

510(k) Number K220349 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 07, 2022
Decision Date August 12, 2022
Days to Decision 186 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
79d slower than avg
Panel avg: 107d · This submission: 186d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 799
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K220349.
AXIR-CX
K213520 · Radisen Co., Ltd. · Aug 2022
WebCeph
K220903 · Assemblecircle Corp. · Aug 2022
syngo Application Software (VE21)
K220433 · Siemens Medical Solution USA, Inc. · Aug 2022
EzDent-i / E2 / Prora View/ Smart M Viewer
K222145 · Ewoosoft Co., Ltd. · Aug 2022
Dolphin Imaging 12.0
K222072 · Patterson Dental Supply, Inc. · Aug 2022
Neurophet SCALE PET
K221405 · Neurophet., Inc. · Aug 2022